How Open Data Is Fueling the AI Drug Discovery Era

Written by Brita Belli
Deep Dives Workflow optimization

In 2008, researchers studying glioblastoma – the most aggressive type of malignant brain tumor –  sequenced 20,000 genes from glioma samples from the Cancer Genome Atlas Program. Gliomas are tumors from the brain or spinal cord that can either remain stable (grade 1), or progress to deadly glioblastomas (grade 4). They wanted to determine whether there might be a genetic driver determining which path the glioma took. The CGAP was an effort launched by the National Cancer Institute and the National Human Genome Research Institute just two years prior. It provided open access to the genes of over 20,000 primary...

Get Free Access in Just 30 Seconds

Register below to unlock all our content - it's completely free.

You will also receive:

  • Exclusive interviews with thought leaders and in-depth analysis
  • Discounted tickets to top industry events like GIANT Health and the London Biotechnology Show